Bowel Cancer Awareness Month
June is Bowel Cancer Awareness Month Bowel cancer is Australia’s second deadliest cancer and claims the lives of 103 Australians every week (5,354 people a year) – but it’s one of the most treatable types of cancer when detected early. While the risk of bowel cancer increases significantly with age, the disease doesn’t discriminate, affecting […]
INVASIVE MENINGOCOCCAL DISEASE (IMD)
NSW Health wishes to advise that meningococcal disease cases are above average for this time of year. A recent cluster of 4 cases, including two deaths, have been in the Illawarra Shoalhaven area. A woman in her late teens from Ulladulla has recently died from meningococcal disease after attending the Spilt Milk festival in Canberra […]
Bone density testing in general practice – the Bone Bus is visiting our practice from 23 – 25 January 2023
“In Australia, every 3.6 minutes, someone is admitted to hospital with an osteoporotic fracture. By 2022 there will be 1 fracture every 2.9 minutes” Osteoporosis is a condition in which the bones become fragile and brittle, leading to a higher risk of fractures (breaks or cracks) than in normal bone. Osteoporosis occurs when bones lose […]
International Day of People with Disability
International Day of People with Disability (IDPwD) is a United Nations (UN) observed day celebrated on 3 December each year. It is a day to acknowledge the contributions and achievements of people with disability and promote awareness, understanding and acceptance in our community. Around one in six people, or 4.4 million Australians, have disability. Not […]
NOVEMBER – LUNG CANCER AWARENESS MONTH
Lung cancer is one of the most common forms of cancer, with more than 2,000,000 people diagnosed worldwide each year, and is the leading cause of cancer death globally. If diagnosed at an earlier stage, patients have a 13 times higher likelihood of living for five years. Smoking is the most common cause of lung […]
Updated eligibility guide for Covid-19 antiviral treatments
The Pharmaceutical Benefits Advisory Committee has recommended expanded eligibility criteria for COVID-19 oral antiviral treatments, Paxlovid (nirmatrelvir and ritonavir) and molnupiravir (Lagevrio). This will be effective from Monday 11 July 2022. This decision is in response to the latest evidence on the effectiveness and safety of the medicines, the rate of uptake since they were made available […]